

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.76511976 |
| 2 | mannose metabolic process (GO:0006013) | 4.64342294 |
| 3 | cell migration in hindbrain (GO:0021535) | 4.33575689 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.24267323 |
| 5 | glutamate secretion (GO:0014047) | 4.21019067 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.17575069 |
| 7 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.06875327 |
| 8 | neurofilament cytoskeleton organization (GO:0060052) | 4.04625786 |
| 9 | proline transport (GO:0015824) | 3.90338959 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 3.84003516 |
| 11 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.76128200 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.67208017 |
| 13 | neuronal action potential propagation (GO:0019227) | 3.63919544 |
| 14 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.62246398 |
| 15 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.60662529 |
| 16 | detection of temperature stimulus (GO:0016048) | 3.58796990 |
| 17 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.56348893 |
| 18 | negative regulation of microtubule polymerization (GO:0031115) | 3.54379297 |
| 19 | sodium ion export (GO:0071436) | 3.53158585 |
| 20 | plasma membrane repair (GO:0001778) | 3.53113214 |
| 21 | cell communication involved in cardiac conduction (GO:0086065) | 3.51909336 |
| 22 | activation of protein kinase A activity (GO:0034199) | 3.49957918 |
| 23 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.48737424 |
| 24 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.48737424 |
| 25 | regulation of ARF protein signal transduction (GO:0032012) | 3.45414907 |
| 26 | membrane depolarization during action potential (GO:0086010) | 3.44097388 |
| 27 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.43660701 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.43023712 |
| 29 | cell communication by electrical coupling (GO:0010644) | 3.36633959 |
| 30 | layer formation in cerebral cortex (GO:0021819) | 3.33341801 |
| 31 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.29850641 |
| 32 | cellular potassium ion homeostasis (GO:0030007) | 3.26641429 |
| 33 | alanine transport (GO:0032328) | 3.23230532 |
| 34 | neuromuscular process controlling posture (GO:0050884) | 3.22954231 |
| 35 | mitochondrion localization (GO:0051646) | 3.20686949 |
| 36 | regulation of ARF GTPase activity (GO:0032312) | 3.19744607 |
| 37 | axon cargo transport (GO:0008088) | 3.19264685 |
| 38 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.18630168 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.17517198 |
| 40 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.17085791 |
| 41 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.16719006 |
| 42 | locomotory exploration behavior (GO:0035641) | 3.16263932 |
| 43 | cell-cell junction maintenance (GO:0045217) | 3.16169554 |
| 44 | regulation of synaptic vesicle transport (GO:1902803) | 3.14048079 |
| 45 | barbed-end actin filament capping (GO:0051016) | 3.11054832 |
| 46 | activation of MAPKKK activity (GO:0000185) | 3.09048681 |
| 47 | organelle transport along microtubule (GO:0072384) | 3.02027593 |
| 48 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.01252528 |
| 49 | regulation of synapse structural plasticity (GO:0051823) | 3.01158618 |
| 50 | mating behavior (GO:0007617) | 3.00303588 |
| 51 | vocalization behavior (GO:0071625) | 2.96328124 |
| 52 | neuron cell-cell adhesion (GO:0007158) | 2.94862508 |
| 53 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.94179377 |
| 54 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.93616977 |
| 55 | negative regulation of type 2 immune response (GO:0002829) | 2.92782202 |
| 56 | vesicle transport along microtubule (GO:0047496) | 2.91801727 |
| 57 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.89715722 |
| 58 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.89662136 |
| 59 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.89461041 |
| 60 | mitochondrion transport along microtubule (GO:0047497) | 2.88516789 |
| 61 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.88516789 |
| 62 | cerebellar granule cell differentiation (GO:0021707) | 2.88130241 |
| 63 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.87187188 |
| 64 | axon extension (GO:0048675) | 2.84797370 |
| 65 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.83468298 |
| 66 | innervation (GO:0060384) | 2.81137456 |
| 67 | gamma-aminobutyric acid transport (GO:0015812) | 2.80722507 |
| 68 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.78250623 |
| 69 | membrane repolarization (GO:0086009) | 2.77146102 |
| 70 | establishment of mitochondrion localization (GO:0051654) | 2.77058051 |
| 71 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76731313 |
| 72 | semaphorin-plexin signaling pathway (GO:0071526) | 2.76437430 |
| 73 | neuronal action potential (GO:0019228) | 2.76177954 |
| 74 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.75844447 |
| 75 | stress fiber assembly (GO:0043149) | 2.75837134 |
| 76 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.75110962 |
| 77 | response to peptidoglycan (GO:0032494) | 2.73526534 |
| 78 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.73101654 |
| 79 | synaptic vesicle endocytosis (GO:0048488) | 2.72951795 |
| 80 | response to muramyl dipeptide (GO:0032495) | 2.71286710 |
| 81 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.70547429 |
| 82 | axonal fasciculation (GO:0007413) | 2.70004359 |
| 83 | dendrite morphogenesis (GO:0048813) | 2.69202119 |
| 84 | signal complex assembly (GO:0007172) | 2.69158762 |
| 85 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.68247667 |
| 86 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.68155535 |
| 87 | protein localization to synapse (GO:0035418) | 2.68078661 |
| 88 | neurotransmitter transport (GO:0006836) | 2.67401841 |
| 89 | neuromuscular synaptic transmission (GO:0007274) | 2.67322707 |
| 90 | macrophage activation involved in immune response (GO:0002281) | 2.64506327 |
| 91 | creatine metabolic process (GO:0006600) | 2.63992451 |
| 92 | glycine transport (GO:0015816) | 2.63362882 |
| 93 | negative regulation of cell size (GO:0045792) | 2.62910922 |
| 94 | neuromuscular process controlling balance (GO:0050885) | 2.62638918 |
| 95 | negative regulation of dendrite development (GO:2000171) | 2.62528739 |
| 96 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.62297994 |
| 97 | positive regulation of synapse maturation (GO:0090129) | 2.61550706 |
| 98 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.61422032 |
| 99 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.60991199 |
| 100 | nucleobase catabolic process (GO:0046113) | 2.60802470 |
| 101 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.59971481 |
| 102 | positive regulation of sodium ion transport (GO:0010765) | 2.59480540 |
| 103 | regulation of membrane repolarization (GO:0060306) | 2.58863342 |
| 104 | Golgi transport vesicle coating (GO:0048200) | 2.58687255 |
| 105 | COPI coating of Golgi vesicle (GO:0048205) | 2.58687255 |
| 106 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.57858406 |
| 107 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.56245296 |
| 108 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.55730978 |
| 109 | regulation of neurotransmitter levels (GO:0001505) | 2.55001102 |
| 110 | positive regulation of axon extension (GO:0045773) | 2.54920212 |
| 111 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.54715803 |
| 112 | histone H4 deacetylation (GO:0070933) | 2.52307274 |
| 113 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.50847564 |
| 114 | exploration behavior (GO:0035640) | 2.49879698 |
| 115 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.49769316 |
| 116 | retrograde transport, endosome to Golgi (GO:0042147) | 2.48595733 |
| 117 | neuron projection extension (GO:1990138) | 2.48229644 |
| 118 | cellular sodium ion homeostasis (GO:0006883) | 2.47592445 |
| 119 | neuron recognition (GO:0008038) | 2.43074186 |
| 120 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.42040745 |
| 121 | positive regulation of potassium ion transport (GO:0043268) | 2.42034809 |
| 122 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.41667176 |
| 123 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.41318242 |
| 124 | glucose 6-phosphate metabolic process (GO:0051156) | 2.40777566 |
| 125 | activation of Rac GTPase activity (GO:0032863) | 2.39352334 |
| 126 | protein localization to endosome (GO:0036010) | 2.39249637 |
| 127 | neuronal ion channel clustering (GO:0045161) | 2.39195571 |
| 128 | cell junction maintenance (GO:0034331) | 2.38543168 |
| 129 | negative regulation of sodium ion transport (GO:0010766) | 2.36043307 |
| 130 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.35932837 |
| 131 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.35932837 |
| 132 | macroautophagy (GO:0016236) | 2.35542976 |
| 133 | positive regulation of axonogenesis (GO:0050772) | 2.33339756 |
| 134 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.32915081 |
| 135 | detection of bacterium (GO:0016045) | 2.32811758 |
| 136 | regulation of neurotransmitter secretion (GO:0046928) | 2.32667757 |
| 137 | potassium ion import (GO:0010107) | 2.32625421 |
| 138 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.31751327 |
| 139 | regulation of regulated secretory pathway (GO:1903305) | 2.31301848 |
| 140 | regulation of leukocyte degranulation (GO:0043300) | 2.30793069 |
| 141 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.30213116 |
| 142 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.30213116 |
| 143 | modulation by symbiont of host immune response (GO:0052553) | 2.30213116 |
| 144 | positive regulation by symbiont of host defense response (GO:0052509) | 2.30213116 |
| 145 | modulation by symbiont of host defense response (GO:0052031) | 2.30213116 |
| 146 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.30213116 |
| 147 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.27424243 |
| 148 | detection of other organism (GO:0098543) | 2.25317277 |
| 149 | tricarboxylic acid metabolic process (GO:0072350) | 2.24486324 |
| 150 | dopamine receptor signaling pathway (GO:0007212) | 2.24068791 |
| 151 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.22801227 |
| 152 | adenosine receptor signaling pathway (GO:0001973) | 2.17544742 |
| 153 | histone H3 deacetylation (GO:0070932) | 2.15990037 |
| 154 | germinal center formation (GO:0002467) | 2.15537014 |
| 155 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.15429384 |
| 156 | regulation of defense response to virus by virus (GO:0050690) | 2.15220280 |
| 157 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.15155349 |
| 158 | actin filament polymerization (GO:0030041) | 2.15118501 |
| 159 | defense response to protozoan (GO:0042832) | 2.14904202 |
| 160 | negative regulation of small GTPase mediated signal transduction (GO:0051058) | 2.14846455 |
| 161 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.13518242 |
| 162 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.11914832 |
| 163 | regulation of type 2 immune response (GO:0002828) | 2.11349119 |
| 164 | negative regulation of interleukin-2 production (GO:0032703) | 2.10130621 |
| 165 | positive regulation of histone deacetylation (GO:0031065) | 2.08442828 |
| 166 | response to manganese ion (GO:0010042) | 2.08354470 |
| 167 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.08198025 |
| 168 | response to protozoan (GO:0001562) | 2.05693830 |
| 169 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.05462090 |
| 170 | negative regulation of cell killing (GO:0031342) | 2.05462090 |
| 171 | regulation of synapse maturation (GO:0090128) | 2.05174391 |
| 172 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.03924232 |
| 173 | amyloid precursor protein catabolic process (GO:0042987) | 2.03583194 |
| 174 | protein insertion into membrane (GO:0051205) | 2.02686655 |
| 175 | thymic T cell selection (GO:0045061) | 2.01096085 |
| 176 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 1.99269297 |
| 177 | focal adhesion assembly (GO:0048041) | 1.98946940 |
| 178 | cell-substrate adherens junction assembly (GO:0007045) | 1.98946940 |
| 179 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 1.98779716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.82737708 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.91128469 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.66400191 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.49928401 |
| 5 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.40450055 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40099324 |
| 7 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.35770434 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.35445741 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34772237 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.20138622 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.19247134 |
| 12 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.18890946 |
| 13 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.18890946 |
| 14 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.18203070 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15807314 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.14309846 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.14032399 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13885361 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.12765875 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.12110392 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.11613058 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10948418 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.06723080 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.04032170 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.03516480 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.00801914 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.99738978 |
| 28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.97357322 |
| 29 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.91307842 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88969960 |
| 31 | P68_20966046_ChIP-Seq_HELA_Human | 1.85915891 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.84188674 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.83780690 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.81805114 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.77086823 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75569534 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.74064999 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.73550548 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71214984 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67652298 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.65396567 |
| 42 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.64971624 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63019358 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61939226 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.60549630 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.60151705 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59400046 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.54525336 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54441367 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54128477 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52912610 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.52454567 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52410694 |
| 54 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.51930703 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50974940 |
| 56 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50332938 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.50090105 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.49819545 |
| 59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.48546637 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47248638 |
| 61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.47186966 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44689156 |
| 63 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42539843 |
| 64 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.40984338 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.40881302 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38208454 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37778302 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37656753 |
| 69 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37352077 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36203542 |
| 71 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36127667 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35616211 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.35423567 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34860844 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34339571 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.33848348 |
| 77 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32540668 |
| 78 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.30770673 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30629960 |
| 80 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.29827262 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29756169 |
| 82 | MAF_26560356_Chip-Seq_TH2_Human | 1.28536718 |
| 83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28068952 |
| 84 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26937221 |
| 85 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26381824 |
| 86 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26212867 |
| 87 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25810616 |
| 88 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24534222 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.24512016 |
| 90 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.23913467 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23515347 |
| 92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21882051 |
| 93 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21365703 |
| 94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21014372 |
| 95 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18966286 |
| 96 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18365729 |
| 97 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17835715 |
| 98 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15278770 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15207420 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14594561 |
| 101 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14546791 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14148124 |
| 103 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.13225755 |
| 104 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12760432 |
| 105 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12543534 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12403921 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11824866 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11505352 |
| 109 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10851364 |
| 110 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.09942696 |
| 111 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.09075092 |
| 112 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08448681 |
| 113 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07840569 |
| 114 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07612454 |
| 115 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07537032 |
| 116 | AR_19668381_ChIP-Seq_PC3_Human | 1.07358764 |
| 117 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07114950 |
| 118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07053126 |
| 119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06478179 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06360824 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06104803 |
| 122 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05815016 |
| 123 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.04015972 |
| 124 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03936156 |
| 125 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03131384 |
| 126 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03082846 |
| 127 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02450751 |
| 128 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02269776 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00893069 |
| 130 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00521908 |
| 131 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00325111 |
| 132 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99949312 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99543717 |
| 134 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99162510 |
| 135 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98872966 |
| 136 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.98835854 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98622983 |
| 138 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.98504353 |
| 139 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.98343699 |
| 140 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.98034963 |
| 141 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97518708 |
| 142 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97233664 |
| 143 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96493416 |
| 144 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96010113 |
| 145 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94683485 |
| 146 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94080850 |
| 147 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94067692 |
| 148 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92470782 |
| 149 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91765139 |
| 150 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91424795 |
| 151 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91133037 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88472628 |
| 153 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87844579 |
| 154 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87270679 |
| 155 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87241627 |
| 156 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87033962 |
| 157 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86520024 |
| 158 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.85494908 |
| 159 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84691285 |
| 160 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84449572 |
| 161 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.84127184 |
| 162 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83149979 |
| 163 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83065367 |
| 164 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82863158 |
| 165 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.82761784 |
| 166 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.82672329 |
| 167 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.80910436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.36274984 |
| 2 | MP0004858_abnormal_nervous_system | 4.04335345 |
| 3 | MP0002735_abnormal_chemical_nociception | 3.91944819 |
| 4 | MP0008260_abnormal_autophagy | 3.91482490 |
| 5 | MP0004270_analgesia | 3.72763104 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.60240499 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.43992753 |
| 8 | MP0003303_peritoneal_inflammation | 3.42055403 |
| 9 | MP0002736_abnormal_nociception_after | 3.21337884 |
| 10 | MP0009278_abnormal_bone_marrow | 3.13348762 |
| 11 | MP0003436_decreased_susceptibility_to | 3.06575907 |
| 12 | MP0002733_abnormal_thermal_nociception | 2.86255169 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.85734667 |
| 14 | MP0006276_abnormal_autonomic_nervous | 2.83054360 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.80487191 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.64706468 |
| 17 | MP0003329_amyloid_beta_deposits | 2.42504764 |
| 18 | MP0005451_abnormal_body_composition | 2.42112202 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.33447206 |
| 20 | MP0001970_abnormal_pain_threshold | 2.30278431 |
| 21 | MP0009046_muscle_twitch | 2.18977812 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.18522355 |
| 23 | MP0000751_myopathy | 2.17084133 |
| 24 | MP0003880_abnormal_central_pattern | 2.14634986 |
| 25 | MP0002184_abnormal_innervation | 2.09230349 |
| 26 | MP0002063_abnormal_learning/memory/cond | 2.08191685 |
| 27 | MP0002909_abnormal_adrenal_gland | 2.07962513 |
| 28 | MP0002064_seizures | 2.07182384 |
| 29 | MP0004510_myositis | 1.97760054 |
| 30 | MP0002272_abnormal_nervous_system | 1.96645775 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.87147691 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.87147691 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.87007308 |
| 34 | MP0009745_abnormal_behavioral_response | 1.81468046 |
| 35 | MP0000955_abnormal_spinal_cord | 1.80188444 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.78264315 |
| 37 | MP0005083_abnormal_biliary_tract | 1.77645360 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.69488826 |
| 39 | MP0002822_catalepsy | 1.61585561 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.61203011 |
| 41 | MP0000778_abnormal_nervous_system | 1.58726523 |
| 42 | MP0002572_abnormal_emotion/affect_behav | 1.57760383 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.54583754 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.52360027 |
| 45 | MP0005025_abnormal_response_to | 1.45554793 |
| 46 | MP0000747_muscle_weakness | 1.43398792 |
| 47 | MP0000604_amyloidosis | 1.41236680 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.40428703 |
| 49 | MP0001984_abnormal_olfaction | 1.39117388 |
| 50 | MP0003724_increased_susceptibility_to | 1.36974583 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.36189265 |
| 52 | MP0002882_abnormal_neuron_morphology | 1.33984999 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.32631456 |
| 54 | MP0001486_abnormal_startle_reflex | 1.31539739 |
| 55 | MP0004130_abnormal_muscle_cell | 1.29611144 |
| 56 | MP0002419_abnormal_innate_immunity | 1.28231498 |
| 57 | MP0003633_abnormal_nervous_system | 1.27954794 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.26673041 |
| 59 | MP0003075_altered_response_to | 1.25269503 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.25163368 |
| 61 | MP0004947_skin_inflammation | 1.24488544 |
| 62 | MP0003634_abnormal_glial_cell | 1.24303134 |
| 63 | MP0008569_lethality_at_weaning | 1.23914325 |
| 64 | MP0005409_darkened_coat_color | 1.23023262 |
| 65 | MP0000920_abnormal_myelination | 1.19271739 |
| 66 | MP0002269_muscular_atrophy | 1.18674465 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.18488033 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.18096676 |
| 69 | MP0004924_abnormal_behavior | 1.17605428 |
| 70 | MP0005386_behavior/neurological_phenoty | 1.17605428 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.17551377 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.16806891 |
| 73 | MP0002751_abnormal_autonomic_nervous | 1.15801018 |
| 74 | MP0001849_ear_inflammation | 1.14627161 |
| 75 | MP0005666_abnormal_adipose_tissue | 1.14324760 |
| 76 | MP0005360_urolithiasis | 1.14310978 |
| 77 | MP0002557_abnormal_social/conspecific_i | 1.14305533 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 1.13417293 |
| 79 | MP0005000_abnormal_immune_tolerance | 1.12853942 |
| 80 | MP0001533_abnormal_skeleton_physiology | 1.12098201 |
| 81 | MP0004084_abnormal_cardiac_muscle | 1.11290887 |
| 82 | MP0003300_gastrointestinal_ulcer | 1.09670815 |
| 83 | MP0005375_adipose_tissue_phenotype | 1.07179845 |
| 84 | MP0003631_nervous_system_phenotype | 1.05809436 |
| 85 | MP0004036_abnormal_muscle_relaxation | 1.05694174 |
| 86 | MP0002229_neurodegeneration | 1.05276134 |
| 87 | MP0005499_abnormal_olfactory_system | 1.05054329 |
| 88 | MP0005394_taste/olfaction_phenotype | 1.05054329 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 1.04695434 |
| 90 | MP0000858_altered_metastatic_potential | 1.04568672 |
| 91 | MP0009840_abnormal_foam_cell | 1.01830884 |
| 92 | MP0001299_abnormal_eye_distance/ | 1.01480786 |
| 93 | MP0005464_abnormal_platelet_physiology | 1.00377989 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.99844964 |
| 95 | MP0005310_abnormal_salivary_gland | 0.98367729 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.98065715 |
| 97 | MP0002723_abnormal_immune_serum | 0.97336768 |
| 98 | MP0000749_muscle_degeneration | 0.96193026 |
| 99 | MP0004233_abnormal_muscle_weight | 0.94099272 |
| 100 | MP0005330_cardiomyopathy | 0.93276335 |
| 101 | MP0004742_abnormal_vestibular_system | 0.92834889 |
| 102 | MP0001790_abnormal_immune_system | 0.91375448 |
| 103 | MP0005387_immune_system_phenotype | 0.91375448 |
| 104 | MP0008874_decreased_physiological_sensi | 0.90930355 |
| 105 | MP0002796_impaired_skin_barrier | 0.90303552 |
| 106 | MP0005670_abnormal_white_adipose | 0.89503239 |
| 107 | MP0005085_abnormal_gallbladder_physiolo | 0.89363856 |
| 108 | MP0003137_abnormal_impulse_conducting | 0.88892742 |
| 109 | MP0003091_abnormal_cell_migration | 0.88674903 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.88275515 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.87902318 |
| 112 | MP0002653_abnormal_ependyma_morphology | 0.87473755 |
| 113 | MP0004142_abnormal_muscle_tone | 0.87003319 |
| 114 | MP0002420_abnormal_adaptive_immunity | 0.86928788 |
| 115 | MP0001800_abnormal_humoral_immune | 0.86797883 |
| 116 | MP0001819_abnormal_immune_cell | 0.86522834 |
| 117 | MP0004085_abnormal_heartbeat | 0.86085997 |
| 118 | MP0000534_abnormal_ureter_morphology | 0.84616805 |
| 119 | MP0002152_abnormal_brain_morphology | 0.83531762 |
| 120 | MP0003879_abnormal_hair_cell | 0.83252750 |
| 121 | MP0005365_abnormal_bile_salt | 0.82739723 |
| 122 | MP0003787_abnormal_imprinting | 0.82614671 |
| 123 | MP0003045_fibrosis | 0.81456976 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.81402907 |
| 125 | MP0005535_abnormal_body_temperature | 0.81393272 |
| 126 | MP0004215_abnormal_myocardial_fiber | 0.81251855 |
| 127 | MP0002148_abnormal_hypersensitivity_rea | 0.81050325 |
| 128 | MP0002752_abnormal_somatic_nervous | 0.80411938 |
| 129 | MP0010234_abnormal_vibrissa_follicle | 0.78678983 |
| 130 | MP0000013_abnormal_adipose_tissue | 0.78566462 |
| 131 | MP0010630_abnormal_cardiac_muscle | 0.78237672 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.78089608 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.77555224 |
| 134 | MP0003632_abnormal_nervous_system | 0.76846219 |
| 135 | MP0004381_abnormal_hair_follicle | 0.76412430 |
| 136 | MP0002452_abnormal_antigen_presenting | 0.75032547 |
| 137 | MP0003122_maternal_imprinting | 0.73776507 |
| 138 | MP0003806_abnormal_nucleotide_metabolis | 0.73361259 |
| 139 | MP0000759_abnormal_skeletal_muscle | 0.73117367 |
| 140 | MP0005501_abnormal_skin_physiology | 0.73075318 |
| 141 | MP0004087_abnormal_muscle_fiber | 0.72295478 |
| 142 | MP0005621_abnormal_cell_physiology | 0.72231397 |
| 143 | MP0002069_abnormal_eating/drinking_beha | 0.71905186 |
| 144 | MP0001502_abnormal_circadian_rhythm | 0.69899675 |
| 145 | MP0003690_abnormal_glial_cell | 0.69079834 |
| 146 | MP0010386_abnormal_urinary_bladder | 0.69040503 |
| 147 | MP0001270_distended_abdomen | 0.68490008 |
| 148 | MP0002972_abnormal_cardiac_muscle | 0.68163152 |
| 149 | MP0000003_abnormal_adipose_tissue | 0.67496193 |
| 150 | MP0002118_abnormal_lipid_homeostasis | 0.67435224 |
| 151 | MP0002090_abnormal_vision | 0.67340442 |
| 152 | MP0000678_abnormal_parathyroid_gland | 0.67090319 |
| 153 | MP0004264_abnormal_extraembryonic_tissu | 0.66957307 |
| 154 | MP0000685_abnormal_immune_system | 0.66774664 |
| 155 | MP0008872_abnormal_physiological_respon | 0.66464071 |
| 156 | MP0009931_abnormal_skin_appearance | 0.66440551 |
| 157 | MP0003566_abnormal_cell_adhesion | 0.66225120 |
| 158 | MP0000716_abnormal_immune_system | 0.65368516 |
| 159 | MP0001835_abnormal_antigen_presentation | 0.64323925 |
| 160 | MP0000681_abnormal_thyroid_gland | 0.62329151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.38430718 |
| 2 | Supranuclear gaze palsy (HP:0000605) | 4.47386012 |
| 3 | Ulnar claw (HP:0001178) | 4.02173268 |
| 4 | Pheochromocytoma (HP:0002666) | 3.92631115 |
| 5 | Action tremor (HP:0002345) | 3.87916971 |
| 6 | Focal seizures (HP:0007359) | 3.84374161 |
| 7 | Visual hallucinations (HP:0002367) | 3.48652381 |
| 8 | Ankle clonus (HP:0011448) | 3.45930192 |
| 9 | Insidious onset (HP:0003587) | 3.42411877 |
| 10 | Termporal pattern (HP:0011008) | 3.42411877 |
| 11 | Neuroendocrine neoplasm (HP:0100634) | 3.38693634 |
| 12 | Difficulty climbing stairs (HP:0003551) | 3.28535817 |
| 13 | Abnormality of the lower motor neuron (HP:0002366) | 3.25904802 |
| 14 | Focal motor seizures (HP:0011153) | 3.21953444 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 3.07516892 |
| 16 | Abnormality of pain sensation (HP:0010832) | 2.92251606 |
| 17 | Impaired pain sensation (HP:0007328) | 2.92251606 |
| 18 | Cerebral aneurysm (HP:0004944) | 2.88254413 |
| 19 | Urinary urgency (HP:0000012) | 2.87958022 |
| 20 | Loss of speech (HP:0002371) | 2.86684978 |
| 21 | Limb dystonia (HP:0002451) | 2.81776858 |
| 22 | Hypercortisolism (HP:0001578) | 2.77603740 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.72061228 |
| 24 | Atonic seizures (HP:0010819) | 2.70591344 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 2.65198922 |
| 26 | Febrile seizures (HP:0002373) | 2.61360245 |
| 27 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.60072508 |
| 28 | Absence seizures (HP:0002121) | 2.59236959 |
| 29 | Generalized tonic-clonic seizures (HP:0002069) | 2.56439879 |
| 30 | Ragged-red muscle fibers (HP:0003200) | 2.55951526 |
| 31 | Truncal ataxia (HP:0002078) | 2.55535539 |
| 32 | Rapidly progressive (HP:0003678) | 2.55053524 |
| 33 | Microvesicular hepatic steatosis (HP:0001414) | 2.53058797 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 2.51183194 |
| 35 | Diminished motivation (HP:0000745) | 2.50179212 |
| 36 | Distal lower limb amyotrophy (HP:0008944) | 2.49838120 |
| 37 | Failure to thrive in infancy (HP:0001531) | 2.49244629 |
| 38 | Hypoventilation (HP:0002791) | 2.47792605 |
| 39 | Abnormality of the corticospinal tract (HP:0002492) | 2.47595735 |
| 40 | Myotonia (HP:0002486) | 2.47569009 |
| 41 | Postural instability (HP:0002172) | 2.47507553 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.46661947 |
| 43 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.46661947 |
| 44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.46661947 |
| 45 | Ventricular fibrillation (HP:0001663) | 2.44671222 |
| 46 | Insomnia (HP:0100785) | 2.44274582 |
| 47 | Neurofibrillary tangles (HP:0002185) | 2.43795379 |
| 48 | J-shaped sella turcica (HP:0002680) | 2.43205162 |
| 49 | Apathy (HP:0000741) | 2.42649616 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.41238622 |
| 51 | Anosmia (HP:0000458) | 2.41125083 |
| 52 | Hand muscle atrophy (HP:0009130) | 2.39308764 |
| 53 | Upper limb amyotrophy (HP:0009129) | 2.38514339 |
| 54 | Distal upper limb amyotrophy (HP:0007149) | 2.38514339 |
| 55 | * Hammertoe (HP:0001765) | 2.38228267 |
| 56 | Spastic gait (HP:0002064) | 2.38080467 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.37446196 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 2.37285223 |
| 59 | Lower limb muscle weakness (HP:0007340) | 2.36173747 |
| 60 | Depression (HP:0000716) | 2.34669323 |
| 61 | Dialeptic seizures (HP:0011146) | 2.32564562 |
| 62 | Broad face (HP:0000283) | 2.31259591 |
| 63 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.30750350 |
| 64 | Torticollis (HP:0000473) | 2.30109128 |
| 65 | Axonal loss (HP:0003447) | 2.29721568 |
| 66 | Onion bulb formation (HP:0003383) | 2.29411729 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.27839514 |
| 68 | Cellulitis (HP:0100658) | 2.25878858 |
| 69 | Epileptic encephalopathy (HP:0200134) | 2.24818128 |
| 70 | Abnormality of macrophages (HP:0004311) | 2.24130374 |
| 71 | Peripheral hypomyelination (HP:0007182) | 2.22138460 |
| 72 | Amblyopia (HP:0000646) | 2.20431762 |
| 73 | Thin bony cortex (HP:0002753) | 2.20357939 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.20119688 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.20119688 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.20119688 |
| 77 | Recurrent bacterial skin infections (HP:0005406) | 2.19562499 |
| 78 | * Distal sensory impairment (HP:0002936) | 2.19398008 |
| 79 | Sudden death (HP:0001699) | 2.16506789 |
| 80 | Gingivitis (HP:0000230) | 2.15515426 |
| 81 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.15259248 |
| 82 | Difficulty running (HP:0009046) | 2.15236390 |
| 83 | Mucopolysacchariduria (HP:0008155) | 2.14677984 |
| 84 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14677984 |
| 85 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.14337314 |
| 86 | Status epilepticus (HP:0002133) | 2.13922994 |
| 87 | Increased connective tissue (HP:0009025) | 2.12780776 |
| 88 | * Foot dorsiflexor weakness (HP:0009027) | 2.11918370 |
| 89 | EMG: neuropathic changes (HP:0003445) | 2.11659259 |
| 90 | Obstructive sleep apnea (HP:0002870) | 2.09122923 |
| 91 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.08256594 |
| 92 | Spastic paraplegia (HP:0001258) | 2.07946154 |
| 93 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.07563837 |
| 94 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.06505012 |
| 95 | Growth hormone excess (HP:0000845) | 2.05691140 |
| 96 | Abnormality of the vocal cords (HP:0008777) | 2.05297385 |
| 97 | Postural tremor (HP:0002174) | 2.05182274 |
| 98 | Cholecystitis (HP:0001082) | 2.05047705 |
| 99 | Abnormal gallbladder physiology (HP:0012438) | 2.05047705 |
| 100 | Recurrent abscess formation (HP:0002722) | 2.03807481 |
| 101 | Clonus (HP:0002169) | 2.03627745 |
| 102 | Neonatal onset (HP:0003623) | 2.03446511 |
| 103 | Paraplegia (HP:0010550) | 2.00932009 |
| 104 | Steppage gait (HP:0003376) | 2.00839730 |
| 105 | Decreased motor nerve conduction velocity (HP:0003431) | 1.98082831 |
| 106 | Hemorrhage of the eye (HP:0011885) | 1.97122242 |
| 107 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.97013263 |
| 108 | Abnormal eating behavior (HP:0100738) | 1.96387256 |
| 109 | Increased IgE level (HP:0003212) | 1.95931620 |
| 110 | Craniofacial dystonia (HP:0012179) | 1.95203289 |
| 111 | Bradykinesia (HP:0002067) | 1.95157552 |
| 112 | Bundle branch block (HP:0011710) | 1.94049513 |
| 113 | Obstructive lung disease (HP:0006536) | 1.93493442 |
| 114 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93493442 |
| 115 | Reticulocytosis (HP:0001923) | 1.93449158 |
| 116 | Upper motor neuron abnormality (HP:0002127) | 1.92538749 |
| 117 | Asymmetric septal hypertrophy (HP:0001670) | 1.92529723 |
| 118 | Focal dystonia (HP:0004373) | 1.92096872 |
| 119 | Amyotrophic lateral sclerosis (HP:0007354) | 1.92026323 |
| 120 | Hyperacusis (HP:0010780) | 1.91600373 |
| 121 | Impaired social interactions (HP:0000735) | 1.91371505 |
| 122 | Abnormal social behavior (HP:0012433) | 1.91371505 |
| 123 | * Abnormality of the foot musculature (HP:0001436) | 1.91357471 |
| 124 | Hypoplasia of the brainstem (HP:0002365) | 1.91140067 |
| 125 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.91140067 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90918033 |
| 127 | Interstitial pulmonary disease (HP:0006530) | 1.90337890 |
| 128 | Mutism (HP:0002300) | 1.88065177 |
| 129 | Pointed chin (HP:0000307) | 1.87719891 |
| 130 | Neuronal loss in central nervous system (HP:0002529) | 1.87254613 |
| 131 | Prolonged QT interval (HP:0001657) | 1.87061606 |
| 132 | Nuclear cataract (HP:0100018) | 1.86437300 |
| 133 | Dysdiadochokinesis (HP:0002075) | 1.85183277 |
| 134 | Rigidity (HP:0002063) | 1.83925304 |
| 135 | Amyloidosis (HP:0011034) | 1.83719140 |
| 136 | Papilledema (HP:0001085) | 1.83241324 |
| 137 | Anomalous pulmonary venous return (HP:0010772) | 1.83062687 |
| 138 | Abnormality of the Achilles tendon (HP:0005109) | 1.81333606 |
| 139 | Dysmetria (HP:0001310) | 1.81326360 |
| 140 | Lower limb amyotrophy (HP:0007210) | 1.81216533 |
| 141 | Syncope (HP:0001279) | 1.80265114 |
| 142 | Increased serum ferritin (HP:0003281) | 1.79506806 |
| 143 | Hypsarrhythmia (HP:0002521) | 1.79260444 |
| 144 | Easy fatigability (HP:0003388) | 1.78749055 |
| 145 | Exotropia (HP:0000577) | 1.78571472 |
| 146 | Hypothermia (HP:0002045) | 1.78524891 |
| 147 | Achilles tendon contracture (HP:0001771) | 1.78075794 |
| 148 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78070950 |
| 149 | Dysautonomia (HP:0002459) | 1.77671682 |
| 150 | Metaphyseal cupping (HP:0003021) | 1.77547981 |
| 151 | Deep venous thrombosis (HP:0002625) | 1.77125233 |
| 152 | Hypertensive crisis (HP:0100735) | 1.77081583 |
| 153 | Abnormal EKG (HP:0003115) | 1.76675856 |
| 154 | EEG with generalized epileptiform discharges (HP:0011198) | 1.76076037 |
| 155 | Stridor (HP:0010307) | 1.75868530 |
| 156 | Mask-like facies (HP:0000298) | 1.74354577 |
| 157 | Flat acetabular roof (HP:0003180) | 1.74228263 |
| 158 | Anxiety (HP:0000739) | 1.73303797 |
| 159 | Hemiplegia (HP:0002301) | 1.72697301 |
| 160 | Exercise-induced myalgia (HP:0003738) | 1.72686951 |
| 161 | Myositis (HP:0100614) | 1.71995017 |
| 162 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71796261 |
| 163 | Gastrointestinal inflammation (HP:0004386) | 1.71509514 |
| 164 | Bowel incontinence (HP:0002607) | 1.71239929 |
| 165 | Hyperthyroidism (HP:0000836) | 1.67560230 |
| 166 | Progressive muscle weakness (HP:0003323) | 1.67554761 |
| 167 | Colitis (HP:0002583) | 1.66088893 |
| 168 | Long palpebral fissure (HP:0000637) | 1.65985658 |
| 169 | Ventricular tachycardia (HP:0004756) | 1.65023461 |
| 170 | Slow saccadic eye movements (HP:0000514) | 1.64789121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 3.70245725 |
| 2 | MAP3K9 | 3.61033919 |
| 3 | LMTK2 | 2.98815761 |
| 4 | MINK1 | 2.95405313 |
| 5 | NTRK3 | 2.91345184 |
| 6 | MARK1 | 2.65213094 |
| 7 | MAPKAPK3 | 2.50640501 |
| 8 | ERN1 | 2.50556927 |
| 9 | MAP3K11 | 2.48913153 |
| 10 | PRPF4B | 2.46615029 |
| 11 | KSR2 | 2.41009052 |
| 12 | MAP3K4 | 2.36818722 |
| 13 | PHKG1 | 2.35972582 |
| 14 | PHKG2 | 2.35972582 |
| 15 | LATS2 | 2.25711670 |
| 16 | MAP2K3 | 2.18446059 |
| 17 | MAP3K2 | 2.04742912 |
| 18 | SMG1 | 2.04482055 |
| 19 | MAP2K4 | 1.98994701 |
| 20 | PAK6 | 1.89703496 |
| 21 | DAPK2 | 1.84656438 |
| 22 | TNK2 | 1.81635265 |
| 23 | NTRK2 | 1.71324707 |
| 24 | EPHB1 | 1.68920812 |
| 25 | KSR1 | 1.63491319 |
| 26 | PRKD2 | 1.56748691 |
| 27 | EEF2K | 1.56393547 |
| 28 | MAP4K1 | 1.54546527 |
| 29 | IRAK3 | 1.52481535 |
| 30 | PRKD3 | 1.52317122 |
| 31 | RET | 1.51774023 |
| 32 | TRIB3 | 1.47202824 |
| 33 | CAMKK1 | 1.40462482 |
| 34 | GRK5 | 1.36397977 |
| 35 | LIMK1 | 1.35062780 |
| 36 | SCYL2 | 1.27798215 |
| 37 | CDK12 | 1.26152549 |
| 38 | ICK | 1.24354777 |
| 39 | SGK223 | 1.24125916 |
| 40 | SGK494 | 1.24125916 |
| 41 | STK38 | 1.23933259 |
| 42 | TBK1 | 1.23217736 |
| 43 | TESK1 | 1.18604786 |
| 44 | MAPK13 | 1.16243405 |
| 45 | TAOK2 | 1.15681405 |
| 46 | SGK3 | 1.12665968 |
| 47 | CAMK1G | 1.11818316 |
| 48 | NEK1 | 1.11106265 |
| 49 | CDK5 | 1.09474687 |
| 50 | PAK3 | 1.09410134 |
| 51 | CAMKK2 | 1.09370273 |
| 52 | MAP2K7 | 1.09078762 |
| 53 | NME2 | 1.08433982 |
| 54 | RPS6KA2 | 1.06073817 |
| 55 | FGFR4 | 1.05423826 |
| 56 | DYRK1B | 1.02865276 |
| 57 | PIM2 | 1.02296332 |
| 58 | TESK2 | 1.00856755 |
| 59 | SGK2 | 0.99058198 |
| 60 | FER | 0.94509036 |
| 61 | MAP2K1 | 0.93617682 |
| 62 | MAP3K6 | 0.93040134 |
| 63 | EPHA4 | 0.92434985 |
| 64 | BLK | 0.90901445 |
| 65 | RPS6KC1 | 0.89710994 |
| 66 | RPS6KL1 | 0.89710994 |
| 67 | WNK1 | 0.87438533 |
| 68 | SIK1 | 0.86613273 |
| 69 | UHMK1 | 0.86549326 |
| 70 | SIK3 | 0.85531437 |
| 71 | CAMK1D | 0.85403222 |
| 72 | JAK3 | 0.81389882 |
| 73 | ARAF | 0.80305596 |
| 74 | MAP3K3 | 0.79393117 |
| 75 | PRKCG | 0.78045933 |
| 76 | PKN2 | 0.77415691 |
| 77 | MAP3K12 | 0.77300781 |
| 78 | PDK4 | 0.75016090 |
| 79 | PDK3 | 0.75016090 |
| 80 | MAP3K13 | 0.74991512 |
| 81 | MATK | 0.74245059 |
| 82 | TTN | 0.73750603 |
| 83 | TYRO3 | 0.69921786 |
| 84 | MARK2 | 0.69327263 |
| 85 | EPHA2 | 0.69240273 |
| 86 | RIPK1 | 0.69108045 |
| 87 | PTK2 | 0.68936944 |
| 88 | ALK | 0.68637693 |
| 89 | FES | 0.68578062 |
| 90 | CSNK1G2 | 0.68400043 |
| 91 | PDGFRA | 0.68302508 |
| 92 | HIPK2 | 0.67651559 |
| 93 | DAPK1 | 0.67203552 |
| 94 | CDK14 | 0.66876933 |
| 95 | MAPK11 | 0.66390047 |
| 96 | CDK18 | 0.65876712 |
| 97 | PRKCH | 0.65553301 |
| 98 | RPS6KA6 | 0.64447954 |
| 99 | PRKCZ | 0.63996203 |
| 100 | CSK | 0.63854052 |
| 101 | EPHB2 | 0.62480727 |
| 102 | TAOK1 | 0.62358678 |
| 103 | STK11 | 0.62231995 |
| 104 | RIPK4 | 0.61571462 |
| 105 | TYK2 | 0.61484271 |
| 106 | ZAP70 | 0.60984447 |
| 107 | MAP3K5 | 0.60474423 |
| 108 | MAP3K1 | 0.60179050 |
| 109 | MAP3K7 | 0.59552716 |
| 110 | JAK2 | 0.59496166 |
| 111 | CDK15 | 0.59151758 |
| 112 | FGR | 0.58184692 |
| 113 | CDC42BPA | 0.58100553 |
| 114 | GRK6 | 0.57537383 |
| 115 | MAPKAPK5 | 0.56756612 |
| 116 | ERBB2 | 0.56461938 |
| 117 | IRAK2 | 0.55795019 |
| 118 | PNCK | 0.55533751 |
| 119 | PTK6 | 0.55449118 |
| 120 | MAP3K10 | 0.54761615 |
| 121 | IRAK4 | 0.54554742 |
| 122 | EPHA3 | 0.54105545 |
| 123 | SIK2 | 0.52612424 |
| 124 | FYN | 0.51560195 |
| 125 | CAMK2A | 0.51207863 |
| 126 | MAPK4 | 0.51118793 |
| 127 | MAP2K6 | 0.50224739 |
| 128 | MAPK12 | 0.50186391 |
| 129 | MAP2K2 | 0.49568256 |
| 130 | CSF1R | 0.48112268 |
| 131 | PDPK1 | 0.47813320 |
| 132 | PTK2B | 0.46247937 |
| 133 | CAMK2B | 0.46169849 |
| 134 | MAPK7 | 0.46083105 |
| 135 | CDK11A | 0.45554480 |
| 136 | ROCK1 | 0.45344966 |
| 137 | MTOR | 0.44123656 |
| 138 | WNK4 | 0.43770269 |
| 139 | ADRBK1 | 0.42799840 |
| 140 | PRKAA1 | 0.40257997 |
| 141 | DDR2 | 0.39802253 |
| 142 | ROCK2 | 0.38936147 |
| 143 | CAMK2G | 0.38822169 |
| 144 | MAPK10 | 0.38363366 |
| 145 | DAPK3 | 0.37605987 |
| 146 | CAMK4 | 0.37178948 |
| 147 | PRKD1 | 0.37152644 |
| 148 | CSNK1G3 | 0.36870636 |
| 149 | BMX | 0.36374736 |
| 150 | PDK1 | 0.36117630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.31432559 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.91583559 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.47268945 |
| 4 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.28340968 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.13430782 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.11481644 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.95281277 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.93920234 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72951784 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64610846 |
| 11 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.63006575 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.56732792 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54375722 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.52960894 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.51335281 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49834996 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47478187 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.46739961 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44987483 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41121375 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.39680332 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.37635174 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35632302 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.34289377 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.33935079 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32601709 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.31997226 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31851654 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30452232 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.29214701 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27996361 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.27835784 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27492940 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26761408 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26311717 |
| 36 | Nicotine addiction_Homo sapiens_hsa05033 | 1.24025219 |
| 37 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.21326465 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20833817 |
| 39 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.19929234 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18964287 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.17946525 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17449973 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17167266 |
| 44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.16412548 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.14599466 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.13578631 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11573906 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11487062 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11391314 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 1.11102264 |
| 51 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.10817487 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07354115 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07329084 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06986253 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06268626 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05357610 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 1.05328165 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04822914 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 1.04009638 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04007413 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03302520 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 1.02400294 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01964678 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01244617 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.98210748 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96550895 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.96247139 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96073140 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96033644 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95053152 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92618816 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.92308436 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91390377 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91212886 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90187265 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89886457 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88556979 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.88260264 |
| 79 | Axon guidance_Homo sapiens_hsa04360 | 0.87807488 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87753172 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86599436 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85786640 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83715383 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83304055 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.81127551 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80541471 |
| 87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79584992 |
| 88 | Long-term depression_Homo sapiens_hsa04730 | 0.77914729 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77802290 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.77694971 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76998259 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75462899 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75239541 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.75122371 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75057165 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.74936925 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.74838401 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.73624819 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73493919 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73447616 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72937386 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72752900 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70680055 |
| 104 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70536105 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70179142 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70046061 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69799600 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69130500 |
| 109 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69007331 |
| 110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68467816 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.67434722 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66985656 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66659964 |
| 114 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64933929 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64926825 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64544604 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.63779147 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.62810783 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62363858 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.61678177 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.61281455 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61134312 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59417384 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58369316 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.58082915 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57510124 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57058447 |
| 128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56508444 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54506242 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53376694 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.53044582 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52638147 |
| 133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52612350 |
| 134 | Measles_Homo sapiens_hsa05162 | 0.51580096 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51102017 |
| 136 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50968663 |
| 137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50104932 |
| 138 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47175175 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46361945 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45292788 |
| 141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44414602 |
| 142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43350386 |
| 143 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41990416 |
| 144 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41259216 |
| 145 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41101508 |
| 146 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40639287 |

